Inflammatory bowel disease integral care units : Evaluation of a nationwide quality certification programme. The GETECCU experience
© 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC. on behalf of United European Gastroenterology..
BACKGROUND: One of the most valued targets in inflammatory bowel disease (IBD) is for physicians to provide and patients to receive a high-level quality of care. This study aimed to evaluate the implementation of a nationwide quality certification programme for IBD units.
METHODS: Identification of quality indicators (QI) for IBD Unit certification was based on Delphi methodology that selected 53 QI, which were subjected to a normalisation process. Selected QI were then used in the certification process. Coordinated by GETECCU, this process began with a consulting round and an audit drill followed by a formal audit carried out by an independent certifying agency. This audit involved the scrutiny of the selected QI in medical records. If 80%-90% compliance was achieved, the IBD unit audited received the qualification of "advanced", and if it exceeded 90% the rating was "excellence". Afterwards, an anonymous survey was conducted among certified units to assess satisfaction with the programme for IBD units.
RESULTS: As of January 2021, 66 IBD units adhere to the nationwide certification programme. Among the 53 units already audited by January 2021, 31 achieved the certification of excellence, 20 the advanced certification, and two did not obtain the certification. The main survey results indicated high satisfaction with an average score of 8.5 out of 10.
CONCLUSION: Certification of inflammatory bowel disease units by GETECCU is the largest nationwide certification programme for IBD units reported. More than 90% of IBD units adhered to the programme achieved the certification.
| Errataetall: |
CommentIn: United European Gastroenterol J. 2021 Sep;9(7):745-747. - PMID 34245668 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
United European gastroenterology journal - 9(2021), 7 vom: 05. Sept., Seite 766-772 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Barreiro-de Acosta, Manuel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Inflammatory bowel disease |
|---|
| Anmerkungen: |
Date Completed 28.02.2022 Date Revised 05.10.2022 published: Print-Electronic CommentIn: United European Gastroenterol J. 2021 Sep;9(7):745-747. - PMID 34245668 Citation Status MEDLINE |
|---|
| doi: |
10.1002/ueg2.12105 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326375465 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326375465 | ||
| 003 | DE-627 | ||
| 005 | 20231225194445.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ueg2.12105 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1087.xml |
| 035 | |a (DE-627)NLM326375465 | ||
| 035 | |a (NLM)34089303 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Barreiro-de Acosta, Manuel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inflammatory bowel disease integral care units |b Evaluation of a nationwide quality certification programme. The GETECCU experience |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.02.2022 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: United European Gastroenterol J. 2021 Sep;9(7):745-747. - PMID 34245668 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC. on behalf of United European Gastroenterology. | ||
| 520 | |a BACKGROUND: One of the most valued targets in inflammatory bowel disease (IBD) is for physicians to provide and patients to receive a high-level quality of care. This study aimed to evaluate the implementation of a nationwide quality certification programme for IBD units | ||
| 520 | |a METHODS: Identification of quality indicators (QI) for IBD Unit certification was based on Delphi methodology that selected 53 QI, which were subjected to a normalisation process. Selected QI were then used in the certification process. Coordinated by GETECCU, this process began with a consulting round and an audit drill followed by a formal audit carried out by an independent certifying agency. This audit involved the scrutiny of the selected QI in medical records. If 80%-90% compliance was achieved, the IBD unit audited received the qualification of "advanced", and if it exceeded 90% the rating was "excellence". Afterwards, an anonymous survey was conducted among certified units to assess satisfaction with the programme for IBD units | ||
| 520 | |a RESULTS: As of January 2021, 66 IBD units adhere to the nationwide certification programme. Among the 53 units already audited by January 2021, 31 achieved the certification of excellence, 20 the advanced certification, and two did not obtain the certification. The main survey results indicated high satisfaction with an average score of 8.5 out of 10 | ||
| 520 | |a CONCLUSION: Certification of inflammatory bowel disease units by GETECCU is the largest nationwide certification programme for IBD units reported. More than 90% of IBD units adhered to the programme achieved the certification | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a inflammatory bowel disease | |
| 650 | 4 | |a quality indicators | |
| 650 | 4 | |a quality of care | |
| 650 | 4 | |a standards | |
| 650 | 4 | |a unit | |
| 700 | 1 | |a Gutiérrez, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Zabana, Yamile |e verfasserin |4 aut | |
| 700 | 1 | |a Beltrán, Belén |e verfasserin |4 aut | |
| 700 | 1 | |a Calvet, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Chaparro, María |e verfasserin |4 aut | |
| 700 | 1 | |a Domènech, Eugeni |e verfasserin |4 aut | |
| 700 | 1 | |a Esteve, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Panés, Julian |e verfasserin |4 aut | |
| 700 | 1 | |a Gisbert, Javier P |e verfasserin |4 aut | |
| 700 | 1 | |a Nos, Pilar |e verfasserin |4 aut | |
| 700 | 0 | |a on behalf GETECCU |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t United European gastroenterology journal |d 2013 |g 9(2021), 7 vom: 05. Sept., Seite 766-772 |w (DE-627)NLM237284804 |x 2050-6414 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:7 |g day:05 |g month:09 |g pages:766-772 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ueg2.12105 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |e 7 |b 05 |c 09 |h 766-772 | ||